Woolworths (ASX:WOW) share price falls after outbidding Wesfarmers for API

Woolworths is looking to outbid its rival for the Priceline pharmacy chain operator…

| More on:
APA share price takeover Two colleagues take on another two colleagues in a tug of war in a high rise building.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Woolworths Group Ltd (ASX: WOW) share price is falling this morning after outbidding rival Wesfarmers Ltd (ASX: WES) for Australian Pharmaceutical Industries Ltd (ASX: API).

At the time of writing, the retail conglomerate’s shares are down 1% to $39.51.

In respect to the others, the Wesfarmers share price is down 0.5% and the API share price is up almost 14%.

What’s happening?

Wesfarmers has been dealt a major blow in its quest to acquire the Priceline pharmacy chain operator.

According to an announcement, Woolworths has submitted a non-binding transaction proposal to API to acquire it for a cash offer price of $1.75 per share by way of a scheme of arrangement.

This values API’s equity at $872 million and represents a 20 cents per share or 12.9% increase over the offer tabled by Wesfarmers last month.

Woolworths has also revealed that it is willing to explore potential alternative control transaction structure options. This includes a takeover bid with a minimum acceptance condition of 50.1%, in order to deliver more value and certainty for API shareholders.

Though, any such alternative transaction structure option would only be pursued by Woolworths with the approval of the API directors.

The good news for Woolworths, but not for Wesfarmers, is that the API Board believes the offer is more favourable to API shareholders than the Wesfarmers scheme. For these reasons, the API Board has determined that the Woolworths proposal is reasonably likely to be a superior proposal, as defined in the Wesfarmers scheme implementation deed.

Accordingly, the API Board has decided to allow Woolworths to undertake confirmatory due diligence to facilitate a binding offer.

Why would Woolies acquire API?

Woolworths Group CEO, Brad Banducci, explained the rationale for acquiring API.

He said: “There is a compelling strategic rationale to support Woolworths Group’s acquisition of API. Health and wellness is a large, fast-growing category and API would be a fantastic addition to our food and everyday needs ecosystem. If successful, we will continue to support API’s community pharmacy partners to deliver better experiences for both customers and pharmacists. We will also work to strengthen API’s wholesale and distribution business to ensure that all Australians continue to have timely, cost-effective access to a full range of PBS and other medicines, via their community pharmacy, regardless of where they live.”

“The combination of the two businesses is expected to lead to material shared benefits and synergies, much of which will be reinvested back into strengthening and growing API and its pharmacy partners. If successful, the transaction is expected to be funded from the Group’s existing balance sheet capacity and to deliver attractive returns for Woolworths Group shareholders over the medium term,” he concluded.

The Woolworths share price is up almost 17% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

Two men in business attire play chess.
Resources Shares

OZ Minerals ‘completely in play’: Broker on BHP takeover bid

BHP's bid for OZ Minerals may not be over...

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Mergers & Acquisitions

Macquarie share price slips despite rumours $3.7 billion acquisition imminent

French company Veolia is divesting itself of the assets to resolve antitrust concerns raised in May by UK regulators.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Mergers & Acquisitions

The OZ Minerals share price is rocketing 35% after BHP bid

Despite knocking back a takeover bid, OZ Minerals shares are going nuts.

Read more »

An investor looks happy holding a finger to his computer screen while holding a coffee cup in a home office scenario.
Mergers & Acquisitions

BHP share price lifts as $8.3b takeover bid rejected

The iron ore giant proposed to snap up its ASX 200 copper-focused peer for $25 per share.

Read more »

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

OZ Minerals share price on watch after miner rejects BHP’s $25 per share takeover offer

OZ Minerals has rejected BHP's takeover offer...

Read more »

asx share price on watch represented by ship captain looking through binoculars
Mergers & Acquisitions

Acquisitions ahoy: Soul Pattinson share price in focus

Financial services is the latest area of potential deals for Soul Pattinson.

Read more »

an engineer in hard hat stands amid solar panels, part of a solar farm, as she holds a tablet in her hand and smiles.
Mergers & Acquisitions

Genex share price climbs 6% amid new takeover rumours

There's speculation another group may launch a bid for the renewable energy company.

Read more »

rising medical asx share price represented by woman stretching happily in bed
Mergers & Acquisitions

ResApp share price explodes 50% on new Pfizer deal

The ResApp share price is launching upwards after Pfizer upped its takeover bid for the company.

Read more »